Codexis, Inc. (CDXS) Financials

CDXS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 129.4 million 86.1 million
Dec. 31, 2025 147.8 million 97.3 million
Sept. 30, 2025 124.0 million 85.4 million
June 30, 2025 138.2 million 82.6 million

CDXS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.3 million 1.4 million
Dec. 31, 2025 19.6 million 2.2 million
Sept. 30, 2025 -7.9 million 2.5 million
June 30, 2025 -20.5 million 2.5 million

CDXS Net Income

No data available :(

CDXS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 65.6 million 40.5 million 29.1 million
Dec. 31, 2025 78.2 million 40.1 million 33.1 million
Sept. 30, 2025 59.2 million 39.7 million 25.8 million
June 30, 2025 66.3 million 39.4 million 29.6 million

CDXS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 90.8 million
Dec. 31, 2025 90.9 million
Sept. 30, 2025 90.3 million
June 30, 2025 85.4 million

CDXS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 176000 10.3 million 9.7 million -
Dec. 31, 2025 520000 10.9 million 10.7 million -
Sept. 30, 2025 182000 13.9 million 11.2 million -
June 30, 2025 2.5 million 12.6 million 12.2 million -

CDXS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 15.2 million 3.3 million
Dec. 31, 2025 38.9 million 3.4 million
Sept. 30, 2025 8.6 million 2.5 million
June 30, 2025 15.3 million 3.4 million

CDXS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

CDXS

Price: $2.48

52 week price:
0.96
3.87

Earnings Per Share: -0.35 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 517700

Ebitda: -9.8 million

Market Capitalization: 254.5 million

Links: